StockpollyBeta
Get App
Popularity #4,338
CNSY · NASDAQ · Medical - Pharmaceuticals

Cerenome (CNSY)

Diagnostic testing and targeted radiotherapy development for central nervous system cancers.

$2.06
After hours+0.02 (+0.79%)
At close$2.04(+7.36%)

In millions of USD, except per-share figures

In millionsQ4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue12111111110
Cost of revenue00000000000
Gross profit11111111110
55555436789
Research & development33332212334
22223323455
General & administrative22223323450
Other expenses00000000000
Operating income−4−3−4−4−4−4−2−4−6−7−9
00110−1470000
Interest income00000000000
Interest expense00400400300
Other non-operating income00−4−1010−70−300
Income before tax−4−3−3−3−4−175−4−6−7−9
Net income from continuing operations−4−3−3−3−4−175−4−6−7−9
Net income−4−3−3−3−4−175−4−6−7−9
EPS, basic−$21,250.00−$18,750.00−$11,250.00−$9,250.00−$16,500.00−$29,750.00$615.00−$1,030.00−$1.04−$1.05−$1.33
EPS, diluted−$21,250.00−$18,750.00−$6,750.00−$9,250.00−$16,500.00−$29,750.00−$162.50−$1.00−$1.05−$1.05−$1.33
Weighted average shares, basic——————00377
Weighted average shares, diluted——————00377
EBITDA−4−31−3−4−135−4−2−7−9
Depreciation & amortization00000000000
EBIT−4−31−3−4−145−4−2−7−9